CIT
Citron Rho-interacting kinase
Also known as: CITK, CRIK, CTRO_HUMAN, KIAA0949, STK21
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O14578
- Gene
- CIT
- Ensembl
- ENSG00000122966
- Chromosome
- 12
- Canonical length
- 2027 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a serine/threonine-protein kinase that functions in cell division. Together with the kinesin KIF14, this protein localizes to the central spindle and midbody, and functions to promote efficient cytokinesis. This protein is involved in central nervous system development. Polymorphisms in this gene are associated with bipolar disorder and risk for schizophrenia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2011]
Canonical amino-acid sequenceUniProt
2027 residues, UniProt reviewed canonical sequence.
>O14578|CIT
1 MLKFKYGARN PLDAGAAEPI ASRASRLNLF FQGKPPFMTQ QQMSPLSREG ILDALFVLFE
61 ECSQPALMKI KHVSNFVRKY SDTIAELQEL QPSAKDFEVR SLVGCGHFAE VQVVREKATG
121 DIYAMKVMKK KALLAQEQVS FFEEERNILS RSTSPWIPQL QYAFQDKNHL YLVMEYQPGG
181 DLLSLLNRYE DQLDENLIQF YLAELILAVH SVHLMGYVHR DIKPENILVD RTGHIKLVDF
241 GSAAKMNSNK MVNAKLPIGT PDYMAPEVLT VMNGDGKGTY GLDCDWWSVG VIAYEMIYGR
301 SPFAEGTSAR TFNNIMNFQR FLKFPDDPKV SSDFLDLIQS LLCGQKERLK FEGLCCHPFF
361 SKIDWNNIRN SPPPFVPTLK SDDDTSNFDE PEKNSWVSSS PCQLSPSGFS GEELPFVGFS
421 YSKALGILGR SESVVSGLDS PAKTSSMEKK LLIKSKELQD SQDKCHKMEQ EMTRLHRRVS
481 EVEAVLSQKE VELKASETQR SLLEQDLATY ITECSSLKRS LEQARMEVSQ EDDKALQLLH
541 DIREQSRKLQ EIKEQEYQAQ VEEMRLMMNQ LEEDLVSARR RSDLYESELR ESRLAAEEFK
601 RKATECQHKL LKAKDQGKPE VGEYAKLEKI NAEQQLKIQE LQEKLEKAVK ASTEATELLQ
661 NIRQAKERAE RELEKLQNRE DSSEGIRKKL VEAEELEEKH REAQVSAQHL EVHLKQKEQH
721 YEEKIKVLDN QIKKDLADKE TLENMMQRHE EEAHEKGKIL SEQKAMINAM DSKIRSLEQR
781 IVELSEANKL AANSSLFTQR NMKAQEEMIS ELRQQKFYLE TQAGKLEAQN RKLEEQLEKI
841 SHQDHSDKNR LLELETRLRE VSLEHEEQKL ELKRQLTELQ LSLQERESQL TALQAARAAL
901 ESQLRQAKTE LEETTAEAEE EIQALTAHRD EIQRKFDALR NSCTVITDLE EQLNQLTEDN
961 AELNNQNFYL SKQLDEASGA NDEIVQLRSE VDHLRREITE REMQLTSQKQ TMEALKTTCT
1021 MLEEQVMDLE ALNDELLEKE RQWEAWRSVL GDEKSQFECR VRELQRMLDT EKQSRARADQ
1081 RITESRQVVE LAVKEHKAEI LALQQALKEQ KLKAESLSDK LNDLEKKHAM LEMNARSLQQ
1141 KLETERELKQ RLLEEQAKLQ QQMDLQKNHI FRLTQGLQEA LDRADLLKTE RSDLEYQLEN
1201 IQVLYSHEKV KMEGTISQQT KLIDFLQAKM DQPAKKKKGL FSRRKEDPAL PTQVPLQYNE
1261 LKLALEKEKA RCAELEEALQ KTRIELRSAR EEAAHRKATD HPHPSTPATA RQQIAMSAIV
1321 RSPEHQPSAM SLLAPPSSRR KESSTPEEFS RRLKERMHHN IPHRFNVGLN MRATKCAVCL
1381 DTVHFGRQAS KCLECQVMCH PKCSTCLPAT CGLPAEYATH FTEAFCRDKM NSPGLQTKEP
1441 SSSLHLEGWM KVPRNNKRGQ QGWDRKYIVL EGSKVLIYDN EAREAGQRPV EEFELCLPDG
1501 DVSIHGAVGA SELANTAKAD VPYILKMESH PHTTCWPGRT LYLLAPSFPD KQRWVTALES
1561 VVAGGRVSRE KAEADAKLLG NSLLKLEGDD RLDMNCTLPF SDQVVLVGTE EGLYALNVLK
1621 NSLTHVPGIG AVFQIYIIKD LEKLLMIAGE ERALCLVDVK KVKQSLAQSH LPAQPDISPN
1681 IFEAVKGCHL FGAGKIENGL CICAAMPSKV VILRYNENLS KYCIRKEIET SEPCSCIHFT
1741 NYSILIGTNK FYEIDMKQYT LEEFLDKNDH SLAPAVFAAS SNSFPVSIVQ VNSAGQREEY
1801 LLCFHEFGVF VDSYGRRSRT DDLKWSRLPL AFAYREPYLF VTHFNSLEVI EIQARSSAGT
1861 PARAYLDIPN PRYLGPAISS GAIYLASSYQ DKLRVICCKG NLVKESGTEH HRGPSTSRSS
1921 PNKRGPPTYN EHITKRVASS PAPPEGPSHP REPSTPHRYR EGRTELRRDK SPGRPLEREK
1981 SPGRMLSTRR ERSPGRLFED SSRGRLPAGA VRTPLSQVNK VWDQSSVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CIT can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 13 nTPM
Expression across tissuesHPA
Tissue
- basal ganglia: 13 nTPM
- cerebral cortex: 13 nTPM
- amygdala: 8.1 nTPM
- thymus: 6.3 nTPM
- bone marrow: 6 nTPM
- hypothalamus: 5.5 nTPM
Single-cell type
- monocyte progenitors: 203 nCPM
- brain inhibitory neurons: 190 nCPM
- erythrocyte progenitors: 141 nCPM
- ependymal cells: 133 nCPM
- oligodendrocyte progenitor cells: 124 nCPM
- brain excitatory neurons: 122 nCPM
Immune cell
- T-reg: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- basal ganglia: 66 nTPM
- cerebral cortex: 53 nTPM
- thalamus: 40 nTPM
- amygdala: 38 nTPM
- white matter: 23 nTPM
- hypothalamus: 21 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CIT.
Disease | AllUniProt
Conditions CIT is implicated in, by any mechanism.
- Microcephaly 17, primary, autosomal recessive (MCPH17) MIM:617090
Disease | GeneticClinVar
25 pathogenic / likely-pathogenic of 779 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Microcephaly 17, primary, autosomal recessive
- Autosomal recessive primary microcephaly
- Inborn genetic diseases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.26
- gnomAD pLI
- 1
- gnomAD missense Z
- 3.82
- DepMap mean gene effect
- -0.5
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- generation of neurons
- mitotic cell cycle
- mitotic cytokinesis
- negative regulation of hippo signaling
- neuron apoptotic process
- positive regulation of cytokinesis
- regulation of actin cytoskeleton organization
Molecular functions
- ATP binding
- PDZ domain binding
- protein kinase binding
- protein serine kinase activity
- protein serine/threonine kinase activity
- protein serine/threonine kinase inhibitor activity
- scaffold protein binding
- SH3 domain binding
- transcription coactivator binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Protein kinase domain
- AGC-kinase, C-terminal
- Citron homology (CNH) domain
- Pleckstrin homology domain
- Protein kinase C-like, phorbol ester/diacylglycerol-binding domain
- Serine/threonine-protein kinase, active site
- Protein kinase-like domain superfamily
- PH-like domain superfamily
- Protein kinase, ATP binding site
- Protein kinase, C-terminal
- C1-like domain superfamily
- Rho-associated Serine/Threonine Kinase
- Protein kinase domain
- PH domain
- Protein kinase C terminal domain
- CNH domain
- Citron Rho-interacting kinase
- Citron Rho-interacting kinase, catalytic domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CIT in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CIT as an antibody target. Whether an autoantibody or antibody against CIT could matter depends on whether native CIT is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CIT is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CIT as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...